ESR

I-ESR imele isilinganiso se-erythrocyte sedimentation. Imvamisa ibizwa nge- "sed rate."

Kuyisivivinyo esilinganisa ngokungaqondile ukuthi kungakanani ukuvuvukala emzimbeni.

Kudingeka isampula yegazi. Isikhathi esiningi, igazi likhishwa emthanjeni ongaphakathi endololwaneni noma ngemuva kwesandla. Isampuli yegazi ithunyelwa elebhu.

Ukuhlolwa kukala ukuthi amangqamuzana abomvu egazi asheshayo (abizwa ngama-erythrocyte) awela kanjani phansi kwethubhu ende, ezacile.

Azikho izinyathelo ezikhethekile ezidingekayo ukulungiselela lolu vivinyo.

Ungase uzwe ubuhlungu obuncane noma isitinyela lapho kufakwa inaliti. Ungase futhi uzizwe ushaywa yisiza ngemuva kokukhishwa kwegazi.

Izizathu zokuthi kungani kungenziwa i- "sed rate" zifaka:

• Imfiva engachazeki
• Izinhlobo ezithile zobuhlungu obuhlangene noma i-arthritis
• Izimpawu zemisipha
• Ezinye izimpawu ezingacacile ezingachazeki

Lokhu kuhlolwa kungasetshenziswa futhi ukuqapha ukuthi ukugula kuyaphendula yini ekwelashweni.

Lokhu kuhlolwa kungasetshenziswa ukuqapha izifo ezivuthayo noma umdlavuza. Ayisetshenziselwa ukuthola isifo esithile.

Kodwa-ke, ukuhlolwa kuyasebenziseka ekutholeni nasekuqapheni:

• Ukuphazamiseka okuzenzakalelayo
• Ukutheleleka kwamathambo
• Izinhlobo ezithile ze-arthritis
• Izifo ezivuthayo

Okwabadala (indlela yeWestergren):

• Abesilisa abangaphansi kweminyaka engama-50 ubudala: ngaphansi kuka-15 mm / hr
• Abesilisa abangaphezu kweminyaka engama-50 ubudala: ngaphansi kuka-20 mm / hr
• Abesifazane abangaphansi kweminyaka engama-50 ubudala: ngaphansi kuka-20 mm / hr
• Abesifazane abangaphezu kweminyaka engama-50 ubudala: ngaphansi kuka-30 mm / hr

Okwezingane (indlela yeWestergren):

• Usana olusanda kuzalwa: 0 to 2 mm / hr
• Usana olusanda kuzalwa ukuthomba: 3 kuye ku-13 mm / hr

Qaphela: mm / hr = amamilimitha ngehora

Ububanzi bamanani ajwayelekile bungahluka kancane phakathi kwamalabhorethri ahlukene. Khuluma nomhlinzeki wakho wezokunakekelwa kwempilo mayelana nencazelo yemiphumela yakho ethile yokuhlolwa.

I-ESR engavamile ingasiza ekuxilongweni, kodwa akubonisi ukuthi unesimo esithile. Olunye uvivinyo cishe ludingeka njalo.

Isilinganiso se-ESR esandisiwe singenzeka kubantu abane:

• Ukushoda kwegazi
• Umdlavuza onjenge-lymphoma noma i-myeloma eminingi
• Isifo sezinso
• Ukukhulelwa
• Isifo sendlala yegilo

Amasosha omzimba asiza ukuvikela umzimba ezintweni eziyingozi. Isifo sokuzivikela komzimba lapho amasosha omzimba ahlasela ngephutha futhi abhubhise izicubu zomzimba ezinempilo. I-ESR ivame ukuphakama kunokujwayelekile kubantu abane-autoimmune disorder.

Izinkinga ezivamile zokuzivikela komzimba zifaka:

• ILupus
• I-Polymyalgia rheumatica
• Isifo samathambo kubantu abadala noma ezinganeni

Amazinga aphezulu kakhulu e-ESR enzeka ngokungajwayelekile komzimba noma ezinye izifo, kufaka phakathi:

• I-vasculitis yokungezwani komzimba
• I-Giant cell arteritis
• I-Hyperfibrinogenemia (amazinga e-fibrinogen akhuphukile egazini)
• IMacroglobulinemia - eyinhloko
• I-Necrotizing vasculitis

Izinga le-ESR elandisiwe kungenzeka ngenxa yezifo ezithile, kufaka phakathi:

• Ukutheleleka nge-bodywide (systemic)
• Ukutheleleka kwamathambo
• Ukutheleleka kwenhliziyo noma ama-valve enhliziyo
• Umkhuhlane we-rheumatic fever
• Ukutheleleka okukhulu kwesikhumba, njenge-erysipelas
• Isifo sofuba

Amazinga aphansi kunokujwayelekile ajwayelekile:

• Ukwehluleka kwenhliziyo yokubopha
• I-Hyperviscosity
• I-Hypofibrinogenemia (kwehle amazinga e-fibrinogen)
• Umdlavuza wegazi
• Amaprotheni aphansi e-plasma (ngenxa yesibindi noma isifo sezinso)
• I-Polycythemia
• I-sickle cell anemia

Izinga le-sedimentation ye-erythrocyte; Isilinganiso seSed; Izinga le-sedimentation

I-Pisetsky DS. Ukuhlolwa kwelabhoratri ezifweni zamathambo. Ku: IGoldman L, iSchafer AI, ama-eds. Imithi yeGoldman-Cecil. Umhla ka-25. IPhiladelphia, PA: Elsevier Saunders; 2016: isahluko 257.

I-Vajpayee N, Graham SS, Bem S. Ukuhlolwa okuyisisekelo kwegazi nomnkantsha. Ku: McPherson RA, Pincus MR, abahleli. UHenry’s Clinical Diagnosis and Management by Laboratory Methods. Umhla ka-23. ISt Louis, MO: Elsevier; 2017: isahluko 30.